Anti-PDHA1 antibody [EPR11098]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(45 Publications)
Anti-PDHA1 antibody [EPR11098] (ab168379) is a rabbit monoclonal antibody detecting PDHA1 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
View Alternative Names
PHE1A, PDHA1, PDHE1-A type I
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling PDHA1 with unpurified ab168379 at 1/100 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunocytochemistry/ Immunofluorescence analysis of HT-29 (Human colorectal adenocarcinoma epithelial cell) cells labeling PDHA1 with Purified ab168379 at 1 : 100 dilution (3.5 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunofluorescent analysis of HepG2 cells labeling PDHA1 with unpurified ab168379 at 1/100 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling PDHA1 with purified ab168379 at 1/40 dilution (10 ug/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilized with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling PDHA1 with unpurified ab168379 at 1/100 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunocytochemistry/Immunofluorescence analysis Jurkat (human acute T cell leukemia) labelling PDHA1 with purified ab168379 at 1/500. Cells were fixed with 100% methanol. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).
Control : PBS only
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human thyroid carcinoma tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling PDHA1 (red) with unpurified ab168379 at 1/10 dilution, or a rabbit IgG (negative) (green).
- IP
Lab
Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)
ab168379 (purified) at 1 : 20 dilution (2ug) immunoprecipitating PDHA1 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 (+) : ab168379 & HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab168379 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (ab168379)
Predicted band size: 43 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)
Detection of PDHA1 by Western Blot of Immunprecipitate. 293T cell lysate immunoprecipitated using unpurified ab168379 at 1/10 dilution; HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
All lanes:
Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (ab168379)
Predicted band size: 43 kDa
false
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat kidney tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse kidney tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- WB
Supplier Data
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (Lambda Protein Phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 43 kDa
false
Exposure time: 26s
- WB
Lab
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Lanes 1 - 3 : Merged signal (red and green). Green - ab168379 observed at 43 kDa. Red - loading control, ab130007, observed at 130 kDa.
ab168379 was shown to recognize PDHA1 in wild-type A549 cells as signal was lost at the expected MW in PDHA1 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and PDHA1 knockout samples were subjected to SDS-PAGE. ab168379 and ab130007 (Mouse anti Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/1000 dilution
Lane 1:
Wild-type A549 whole cell lysate at 20 µg
Lane 2:
PDHA1 knockout A549 whole cell lysate at 20 µg
Lane 2:
Western blot - Human PDHA1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-pdha1-knockout-a549-cell-line-ab261866'>ab261866</a>)
Lane 3:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Predicted band size: 43 kDa
Observed band size: 43 kDa
false
- WB
Supplier Data
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the band higher than 250 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-PDHA1 antibody (ab168379) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-PDHA1 (phospho S300) antibody [EPR29824-87] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s300-antibody-epr29824-87-ab324265'>ab324265</a>) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
HeLa treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 4:
NIH/3T3 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg
Lane 5:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 6:
HeLa treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 7:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 8:
NIH/3T3 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 43 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab325169 was shown to bind specifically to PDHA1. Target of interest was observed at 43 kDa in induced wild-type A549 cell lysates (lane 2) with no signal observed at this size in induced PDHA1 knockout cell line (lane 4).
Lanes 1-4 on the left untreated membrane with Lambda Protein Phosphatase; Lanes 1-4 on the right treated membrane with Lambda Protein Phosphatase.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution
Lane 1:
Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
A549 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate at 20 µg
Lane 3:
Untreated PDHA1 knockout A549 whole cell lysate at 20 µg
Lane 4:
PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 43 kDa,36 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/2000 dilution
Lane 1:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
Mouse brain lysates at 20 µg
Lane 3:
Rat brain lysates at 20 µg
Lane 4:
Mouse kidney lysates at 20 µg
Lane 5:
Rat kidney lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 43 kDa
false
- WB
Supplier Data
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab324265 was shown to bind specifically toPDHA1 (phospho S300). Target of interest was observed at 43 kDa in Wild-type A549 treated with 100ng/ml Calyculin A (lane 2), with no signal observed at this size in PDHA1 knockout cell line (lanes 3-4).
The identity of the band higher than 250 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-PDHA1 antibody (ab168379) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-PDHA1 (phospho S300) antibody [EPR29824-87] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s300-antibody-epr29824-87-ab324265'>ab324265</a>) at 1/1000 dilution
Lane 1:
Untreated Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
Wild-type A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated PDHA1 knockout A549 whole cell lysate (untreated membrane) at 20 µg
Lane 4:
PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg
Lane 5:
Untreated Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 6:
Wild-type A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 7:
Untreated PDHA1 knockout A549 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 8:
PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 43 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
NIH/3T3 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
NIH/3T3 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate (Lambda Protein Phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 43 kDa
false
Exposure time: 10s
- WB
Unknown
Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
All lanes:
Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/1000 dilution
Lane 1:
Human fetal kidney lysate at 10 µg
Lane 2:
A549 lysate at 10 µg
Lane 3:
Jurkat lysate at 10 µg
Lane 4:
HepG2 lysate at 10 µg
Lane 5:
HeLa lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 43 kDa
false
Related conjugates and formulations (7)
-
Anti-PDHA1 antibody [EPR11098] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-PDHA1 antibody [EPR11098]
-
HRP Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]
-
578 PE
PE Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]
Reactivity data
Product details
What is this antibody validated in?
Anti-PDHA1 antibody [EPR11098] (ab168379) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of PDHA1?
Anti-PDHA1 [EPR11098] (ab168379) specifically detects a band for PDHA1 (UniProt: P08559) at a molecular weight of 43kDa.
Trusted by the scientific community
Anti-PDHA1 [EPR11098] (ab168379) was first used in a scientific publication in 2013 and has been cited over 30 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-PDHA1 antibody [EPR11098] (ab168379) has been confirmed by Western blot testing in PDHA1 Knockout HeLa cells.
Other related products
We have a range of other formats of antibody clone [EPR11098] also available for your convenience: ab168379, Carrier free - ab176835, PE - ab305779, HRP - ab305781, Alkaline Phosphatase - ab308723, Alexa Fluor® 488 - ab309686, Alexa Fluor® 647 - ab310050, Alexa Fluor® 594 - ab310440, Alexa Fluor® 555 - ab311968, Alexa Fluor® 750 - ab321159
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDHA1 engages in the conversion of pyruvate into acetyl-CoA an important step in cellular respiration. This protein is part of the PDH complex which consists of multiple copies of three catalytic and two regulatory subunits. The conversion process is essential for linking glycolysis to the citric acid cycle efficiently channeling energy substrates within the cell. Furthermore the functional activity of PDHA1 is regulated through phosphorylation by the pyruvate dehydrogenase kinases (PDKs) and dephosphorylation by PDH phosphatases.
Pathways
PDHA1 is integral to the metabolic pathway of cellular respiration and energy production. It enables the transition between glycolysis and the citric acid cycle by facilitating the conversion of pyruvate to acetyl-CoA which enters the citric acid cycle. Related proteins in this pathway include PDHA2 and the regulatory PDKs that modulate PDHA1 activity. These interactions ensure energy metabolism adapts to various cellular conditions influencing energy balance and substrate utilization.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (45)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3177 PubMed40180922
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:2409-2425 PubMed39933533
2025
Applications
Unspecified application
Species
Unspecified reactive species
JACS Au 5:302-319 PubMed39886595
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature metabolism 7:212-227 PubMed39809975
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed39796278
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 8:258 PubMed39521913
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pharmacological research 207:107336 PubMed39094987
2024
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 14:1441-1454 PubMed38952051
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials research 28:0035 PubMed38840655
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 36:1394-1410.e12 PubMed38838644
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com